• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利儿科学会关于川崎病一般治疗的修订建议。

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease.

机构信息

Bambino Gesù Children's Hospital, Rome, Italy.

Department of Life Sciences and Public Health, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.

出版信息

Ital J Pediatr. 2021 Jan 25;47(1):16. doi: 10.1186/s13052-021-00962-4.

DOI:10.1186/s13052-021-00962-4
PMID:33494789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7830049/
Abstract

Aim of these revised recommendations for the general management of Kawasaki disease is to encourage its prompter recognition and warrant the most appropriate therapy, based on ascertained scientific data, raising awareness of the complications related to misdiagnosis or delayed treatment. A set of 20 synthetic operative statements is herein provided, including the definition of Kawasaki disease, its protean presentations, clinical course and seminal treatment modalities of all disease phases. The application of these recommendations should improve prognosis of Kawasaki disease and prevent the progression to permanent vascular abnormalities, thereby diminishing morbidity and mortality.

摘要

这些修订版川崎病一般治疗建议的目的,是鼓励更迅速地识别川崎病,并根据已确定的科学数据,为其提供最合适的治疗,同时提高对误诊或治疗延误相关并发症的认识。本文提供了一套 20 个综合操作性陈述,包括川崎病的定义、其多变的表现、临床病程和所有疾病阶段的主要治疗方式。这些建议的应用应能改善川崎病的预后,防止其进展为永久性血管异常,从而降低发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e89/7831257/a7cebe422f45/13052_2021_962_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e89/7831257/f9c5a079fe45/13052_2021_962_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e89/7831257/a7cebe422f45/13052_2021_962_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e89/7831257/f9c5a079fe45/13052_2021_962_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e89/7831257/a7cebe422f45/13052_2021_962_Fig2_HTML.jpg

相似文献

1
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease.意大利儿科学会关于川崎病一般治疗的修订建议。
Ital J Pediatr. 2021 Jan 25;47(1):16. doi: 10.1186/s13052-021-00962-4.
2
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.川崎病:意大利儿科学会指南,第一部分-定义、流行病学、病因发病机制、急性期临床表现和治疗。
Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3.
3
The Complexities of the Diagnosis and Management of Kawasaki Disease.川崎病诊断与管理的复杂性
Infect Dis Clin North Am. 2015 Sep;29(3):525-37. doi: 10.1016/j.idc.2015.05.006. Epub 2015 Jul 4.
4
[Kawasaki disease--two case reports].[川崎病——两例病例报告]
Pol Merkur Lekarski. 1997 Jul;3(13):20-1.
5
Reiter syndrome initially misdiagnosed as Kawasaki disease.赖特综合征最初被误诊为川崎病。
J Pediatr. 1996 Mar;128(3):366-9. doi: 10.1016/s0022-3476(96)70283-4.
6
Kawasaki disease.川崎病
Rheum Dis Clin North Am. 2015;41(1):63-73, viii. doi: 10.1016/j.rdc.2014.09.010.
7
Kawasaki disease shock syndrome: a rare and severe complication of Kawasaki disease.川崎病休克综合征:川崎病一种罕见且严重的并发症。
Turk J Pediatr. 2016;58(4):415-418. doi: 10.24953/turkjped.2016.04.012.
8
Kawasaki disease thirty years on.川崎病三十年回顾
Curr Opin Pediatr. 1998 Feb;10(1):24-33. doi: 10.1097/00008480-199802000-00006.
9
Incomplete (atypical) Kawasaki disease.不完全(非典型)川崎病
Pediatr Infect Dis J. 2002 Jun;21(6):563-5. doi: 10.1097/00006454-200206000-00015.
10
Kawasaki disease: etiopathogenesis and novel treatment strategies.川崎病:病因发病机制与新型治疗策略
Expert Rev Clin Immunol. 2017 Mar;13(3):247-258. doi: 10.1080/1744666X.2017.1232165. Epub 2016 Sep 13.

引用本文的文献

1
The protective role of steroids on coronary arteries in the acute phase of Kawasaki disease for high risk patients: a retrospective study.类固醇对川崎病急性期高危患者冠状动脉的保护作用:一项回顾性研究。
Front Pediatr. 2025 Aug 28;13:1636339. doi: 10.3389/fped.2025.1636339. eCollection 2025.
2
MIS-C, inherited metabolic diseases and methylmalonic acidemia: a case report and review of the literature.儿童多系统炎症综合征、遗传性代谢疾病与甲基丙二酸血症:一例病例报告及文献综述
Ital J Pediatr. 2025 Jul 1;51(1):202. doi: 10.1186/s13052-025-02052-1.
3
Multisystem inflammatory syndrome in children and Kawasaki disease.

本文引用的文献

1
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.儿童 COVID-19 相关多系统炎症综合征的免疫学。
Cell. 2020 Nov 12;183(4):968-981.e7. doi: 10.1016/j.cell.2020.09.016. Epub 2020 Sep 6.
2
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review.阿那白滞素治疗川崎病:文献复习的证据。
Paediatr Drugs. 2020 Dec;22(6):645-652. doi: 10.1007/s40272-020-00421-3.
3
Overview of the rarest causes of fever in newborns: handy hints for the neonatologist.新生儿发热罕见病因概述:新生儿科医生的实用提示。
儿童多系统炎症综合征与川崎病
Front Immunol. 2025 Apr 15;16:1554787. doi: 10.3389/fimmu.2025.1554787. eCollection 2025.
4
Contemporary Diagnosis, Management, and Early Outcomes in Children with Kawasaki Disease in Romania: A Single-Center Experience.罗马尼亚川崎病患儿的当代诊断、管理及早期结局:单中心经验
Diagnostics (Basel). 2025 Mar 7;15(6):656. doi: 10.3390/diagnostics15060656.
5
Drug-Induced Liver Injury-Pharmacological Spectrum Among Children.儿童药物性肝损伤的药理学谱
Int J Mol Sci. 2025 Feb 25;26(5):2006. doi: 10.3390/ijms26052006.
6
Coronary Arteries Lesions in Kawasaki Disease: Risk Factors in an Italian Cohort.川崎病中的冠状动脉病变:意大利队列中的危险因素
Biomedicines. 2024 Sep 3;12(9):2010. doi: 10.3390/biomedicines12092010.
7
Coronary thrombosis and myocardial ischemia in Kawasaki disease: a case report.川崎病致冠状动脉血栓形成并心肌缺血 1 例报告。
BMC Cardiovasc Disord. 2024 Sep 5;24(1):473. doi: 10.1186/s12872-024-04148-8.
8
Metagenomic analysis demonstrates distinct changes in the gut microbiome of Kawasaki diseases children.宏基因组分析表明川崎病患儿肠道微生物组有明显变化。
Front Immunol. 2024 Jul 22;15:1416185. doi: 10.3389/fimmu.2024.1416185. eCollection 2024.
9
Cardiovascular involvement in children with COVID-19 temporally related multisystem inflammatory syndrome (MIS-C): can cardiac magnetic resonance arrive to the heart of the problem?儿童 COVID-19 相关多系统炎症综合征(MIS-C)中的心血管受累:心脏磁共振能否直击问题核心?
Ital J Pediatr. 2024 May 3;50(1):91. doi: 10.1186/s13052-024-01658-1.
10
[Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023)].《中国儿童川崎病诊断与治疗循证指南(2023年版)》
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Dec 15;25(12):1198-1210. doi: 10.7499/j.issn.1008-8830.2309038.
J Perinatol. 2021 Mar;41(3):372-382. doi: 10.1038/s41372-020-0744-8. Epub 2020 Jul 27.
4
Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.川崎病作为病毒感染的免疫介导回声。
Mediterr J Hematol Infect Dis. 2020 Jul 1;12(1):e2020039. doi: 10.4084/MJHID.2020.039. eCollection 2020.
5
Phenotype variability of autoinflammatory disorders in the pediatric patient: A pictorial overview.儿童自身炎症性疾病的表型变异性:图像概述。
J Evid Based Med. 2020 Aug;13(3):227-245. doi: 10.1111/jebm.12406. Epub 2020 Jul 6.
6
Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic.2019年新型冠状病毒病(COVID-19)大流行期间川崎病的漏诊或延迟诊断。
J Pediatr. 2020 Jul;222:261-262. doi: 10.1016/j.jpeds.2020.04.052. Epub 2020 May 3.
7
Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.土耳其川崎病患儿静脉注射免疫球蛋白抵抗和冠状动脉病变的危险因素。
Turk J Pediatr. 2020;62(1):1-9. doi: 10.24953/turkjped.2020.01.001.
8
Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study.川崎病不同年龄谱的临床表现:十年研究。
Medicina (Kaunas). 2020 Mar 25;56(4):145. doi: 10.3390/medicina56040145.
9
Platelets in Kawasaki disease: Is this only a numbers game or something beyond?川崎病中的血小板:这仅仅是数字游戏还是另有深意?
Genes Dis. 2019 Sep 12;7(1):62-66. doi: 10.1016/j.gendis.2019.09.003. eCollection 2020 Mar.
10
What dose of aspirin should be used in the initial treatment of Kawasaki disease? A meta-analysis.川崎病初始治疗中应使用多大剂量的阿司匹林?一项荟萃分析。
Rheumatology (Oxford). 2020 Aug 1;59(8):1826-1833. doi: 10.1093/rheumatology/keaa050.